Vincent Charles Dubesky , PA-C
Physician Assistant • Lancaster, PA
1808 Colonial Village Ln Ste 103
Lancaster, PA 176016709
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Vincent Dubesky is listed in NPPES under Physician Assistant.
-
NPI assigned on June 1, 2022; this date does not establish years in practice.
-
Published CMS data list 3,507 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Trazodone Hcl — 218 prescription fills, including refills.
- Sertraline Hcl — 174 prescription fills, including refills.
- Olanzapine — 162 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 61 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Part D prescriptions than 95% of clinicians listed under Physician Assistant in Lancaster, PA (2024, 107 clinicians with data). Median for this group: 266. Middle half: 83 to 752.
More Part D prescriptions than 90% of clinicians listed under Physician Assistant in Pennsylvania (2024, 4,373 clinicians with data). Median for this group: 235. Middle half: 69 to 862.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part D prescriptions went from 188 in 2022 to 3,507 in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2022–2024.
Practice Location & Contact Primary Location
1808 Colonial Village Ln Ste 103
Lancaster, PA 176016709
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
Physician Assistant: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
4,251 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$549,915 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $2,576.23 across 112 records.
By nature of payment
- Food and Beverage: $2,395.75 across 110 records.
- Education: $180.48 across 2 records.
Reporting-company totals (3 largest of 14)
- Teva Pharmaceuticals USA, Inc.: $486.19 across 17 records.
- ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.): $428.97 across 17 records.
- Bristol Myers Squibb Company: $381.92 across 15 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
NPI first issued
2022
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Compared with the same specialty in Lancaster and Pennsylvania
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
More Part D prescriptions than 95% of clinicians listed under Physician Assistant in Lancaster, PA (2024, 107 clinicians with data). Median for this group: 266. Middle half: 83 to 752.
More Part D prescriptions than 90% of clinicians listed under Physician Assistant in Pennsylvania (2024, 4,373 clinicians with data). Median for this group: 235. Middle half: 69 to 862.
Part D drug cost
A higher Part D drug cost than 95% of clinicians listed under Physician Assistant in Lancaster, PA (2024, 107 clinicians with data). Median for this group: $1,576. Middle half: $610 to $37,807.
A higher Part D drug cost than 90% of clinicians listed under Physician Assistant in Pennsylvania (2024, 4,373 clinicians with data). Median for this group: $3,681. Middle half: $519 to $94,109.
166 active clinicians are listed under Physician Assistant with a practice address in Lancaster, PA (8,021 in Pennsylvania).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Lancaster
13.9% of these 166 clinicians have the CMS telehealth indicator.
77.7% of these 166 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 1765% from 188 in 2022 to 3,507 in 2024.
- 2022: 188
- 2023: 2,267
- 2024: 3,507
-
30-day fills
30-day fills increased 2031% from 200 in 2022 to 4,251 in 2024.
- 2022: 200
- 2023: 2,643
- 2024: 4,251
-
Part D drug cost
Part D drug cost increased 9035% from $6,020 in 2022 to $549,915 in 2024.
- 2022: $6,020
- 2023: $277,293
- 2024: $549,915
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $415.91 in 2022 to $2,576.23 in 2025.
- 2022: $415.91
- 2023: $1,906.71
- 2024: $2,455.46
- 2025: $2,576.23
Sources: CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 112 records totaling $2,576.23.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Neurocrine BioSciences, Inc. |
Food and Beverage
In-kind items and services
|
INGREZZA | General | $125.00 |
| Alkermes, Inc. |
Food and Beverage
In-kind items and services
|
LYBALVI | General | $109.02 |
| Bristol Myers Squibb Company |
Food and Beverage
Cash or cash equivalent
|
COBENFY | General | $108.17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) |
Food and Beverage
In-kind items and services
|
CAPLYTA | General | $102.44 |
| Teva Pharmaceuticals USA, Inc. |
Education
In-kind items and services
|
— | General | $92.99 |
| Teva Pharmaceuticals USA, Inc. |
Education
In-kind items and services
|
— | General | $87.49 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) |
Food and Beverage
In-kind items and services
|
CAPLYTA | General | $32.90 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) |
Food and Beverage
In-kind items and services
|
CAPLYTA | General | $32.46 |
| Bristol Myers Squibb Company |
Food and Beverage
Cash or cash equivalent
|
COBENFY | General | $32.46 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
SPRAVATO | General | $30.93 |
| Teva Pharmaceuticals USA, Inc. |
Food and Beverage
In-kind items and services
|
UZEDY | General | $30.75 |
| Teva Pharmaceuticals USA, Inc. |
Food and Beverage
In-kind items and services
|
AUSTEDO XR | General | $30.18 |
| Bristol Myers Squibb Company |
Food and Beverage
Cash or cash equivalent
|
COBENFY | General | $30.14 |
| Teva Pharmaceuticals USA, Inc. |
Food and Beverage
In-kind items and services
|
AUSTEDO XR | General | $30.09 |
| Lundbeck LLC |
Food and Beverage
Cash or cash equivalent
|
REXULTI | General | $29.94 |
| Otsuka America Pharmaceutical, Inc. |
Food and Beverage
In-kind items and services
|
ABILIFY ASIMTUFII | General | $29.07 |
| Axsome Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
Auvelity | General | $28.65 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
VRAYLAR | General | $28.47 |
| Bristol Myers Squibb Company |
Food and Beverage
Cash or cash equivalent
|
COBENFY | General | $27.66 |
| Axsome Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
Auvelity | General | $27.24 |
| Alkermes, Inc. |
Food and Beverage
In-kind items and services
|
LYBALVI | General | $26.96 |
| Otsuka America Pharmaceutical, Inc. |
Food and Beverage
In-kind items and services
|
ABILIFY ASIMTUFII | General | $26.92 |
| Axsome Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
Auvelity | General | $26.32 |
| Teva Pharmaceuticals USA, Inc. |
Food and Beverage
In-kind items and services
|
UZEDY | General | $26.22 |
| Teva Pharmaceuticals USA, Inc. |
Food and Beverage
In-kind items and services
|
UZEDY | General | $26.15 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Trazodone Hcl | Trazodone Hcl | 218 | 8,088 | $1,336.03 | 32 |
| Sertraline Hcl | Sertraline Hcl | 174 | 6,485 | $1,310.97 | 25 |
| Olanzapine | Olanzapine | 162 | 5,280 | $3,332.09 | 21 |
| Aripiprazole | Aripiprazole | 157 | 5,509 | $7,611.44 | 22 |
| Escitalopram Oxalate | Escitalopram Oxalate | 153 | 4,746 | $1,061.49 | 23 |
| Clozapine | Clozapine | 141 | 2,476 | $3,759.06 | — |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 137 | 4,929 | $3,318.32 | 14 |
| Bupropion Xl | Bupropion Hcl | 114 | 5,194 | $2,578.42 | 21 |
| Buspirone Hcl | Buspirone Hcl | 110 | 4,239 | $1,237.91 | 18 |
| Lamotrigine | Lamotrigine | 109 | 4,062 | $533.15 | 18 |
| Quetiapine Fumarate | Quetiapine Fumarate | 104 | 4,122 | $1,406.06 | 14 |
| Vraylar | Cariprazine Hcl | 99 | 2,782 | $128,720.65 | 12 |
| Divalproex Sodium Er | Divalproex Sodium | 92 | 3,092 | $2,986.40 | 15 |
| Duloxetine Hcl | Duloxetine Hcl | 91 | 4,109 | $1,375.39 | 18 |
| Clonidine Hcl | Clonidine Hcl | 83 | 3,053 | $256.83 | 12 |
| Propranolol Hcl | Propranolol Hcl | 75 | 2,553 | $916.60 | 22 |
| Risperidone | Risperidone | 74 | 3,390 | $931.21 | 13 |
| Fluoxetine Hcl | Fluoxetine Hcl | 73 | 2,293 | $286.45 | 12 |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 72 | 2,209 | $921.83 | 16 |
| Mirtazapine | Mirtazapine | 71 | 2,849 | $1,324.40 | 15 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 71 | 2,494 | $823.66 | 16 |
| Benztropine Mesylate | Benztropine Mesylate | 70 | 2,457 | $697.55 | 13 |
| Haloperidol | Haloperidol | 68 | 2,414 | $3,099.38 | — |
| Prazosin Hcl | Prazosin Hcl | 59 | 1,967 | $751.07 | 12 |
| Clonazepam | Clonazepam | 52 | 1,498 | $437.23 | 11 |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2024-04-08NUCC Taxonomy Code: 363A00000X
A physician assistant is a person who has successfully completed an accredited education program for physician assistant, is licensed by the state and is practicing within the scope of that license. Physician assistants are formally trained to perform many of the routine, time-consuming tasks a physician can do. In some states, they may prescribe medications. They take medical histories, perform physical exams, order lab tests and x-rays, and give inoculations. Most states require that they work under the supervision of a physician.
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Psychiatry & Neurology - Psychiatry
Doctor of Osteopathic Medicine (D.O.)
Psychiatry & Neurology - Psychiatry
Doctor of Medicine (M.D.)
Physician Assistant - Medical
Physician Assistant (Certified)
Physician Assistant
Physician Assistant (Certified)
Psychiatry & Neurology - Child & Adolescent Psychiatry
Doctor of Medicine (M.D.)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Physician Assistant (license number reported to NPPES: PA MA063621)
Physician Assistant
NPI status registered as active in NPPES database
Registered at 1808 COLONIAL VILLAGE LN STE 103, LANCASTER, PA 176016709 (Tel: 7173910172)
Registered at 1808 COLONIAL VILLAGE LN STE 103, LANCASTER, PA 176016709 (Tel: 7173910172)
Recorded as VINCENT DUBESKY, PA-C
Physician Assistant
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Physician Assistants in Lancaster
- Anthony Hackett, PA-C
- Elise Benjamin
- Pankaj Gupta, PA-C
- Craig Lehmann, PA-C
- Francis Horner, PA-C
- Amber Helsel, PA-C
Mailing Address
1808 Colonial Village Ln Ste 103
Lancaster, PA 176016709
Phone: 7173910172